Quick Answer
Sensei Biotherapeutics, Inc. reported Stockholders Equity of $18.59 million for fiscal year 2025.
Sensei Biotherapeutics, Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $18.59M | -51.6% |
| 2024 | $38.39M | -40.8% |
| 2023 | $64.89M | -37.2% |
| 2022 | $103.41M | -29.4% |
| 2021 | $146.51M | +359.6% |
| 2020 | -$56.44M | +17.8% |
| 2019 | -$68.66M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $23.01M | -49.7% | -15.8% |
| June 30, 2025 | $27.31M | -47.7% | -14.6% |
| March 31, 2025 | $31.99M | -45.3% | -16.7% |
| December 31, 2024 | $38.39M | -40.8% | -16.1% |
| September 30, 2024 | $45.78M | -35.5% | -12.3% |
| June 30, 2024 | $52.19M | -34.1% | -10.7% |
| March 31, 2024 | $58.47M | -38.4% | -9.9% |
| December 31, 2023 | $64.89M | -37.2% | -8.6% |
- Sensei Biotherapeutics, Inc. showed a decrease of -51.6% in Stockholders Equity compared to the prior fiscal year.
- Over the 2019–2025 period, Sensei Biotherapeutics, Inc.’s stockholders equity has grown by 127.1% (from -$68.66 million to $18.59 million).
- The most recent figure is from Sensei Biotherapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: